China Cord Blood beats by $0.03, misses on revenues

China Cord Blood (CO): FQ1 EPS of $0.07 beats by $0.03.

Revenue of $21M misses by $0.62M. (PR)

From other sites
Comments (1)
  • stem333
    , contributor
    Comments (2) | Send Message
    I own this stock and i am impresses with the earnings being a 175%


    of the estimate. In ten years at this same trend without any additional


    licenses, this stock could easily be at 40-50 dollars per share. my


    current value estimate of this stock is $6.50 dollars per share


    27 Aug 2013, 07:55 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs